E. Sirmans

发表

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

E. Le Chatelier, N. Pons, N. Ajami, 2018, Science.

Erratum to: A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1

P. Hwu, C. Hudgens, M. Tetzlaff, 2017, Journal of Immunotherapy for Cancer.

A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1

P. Hwu, C. Hudgens, M. Tetzlaff, 2016, Journal of Immunotherapy for Cancer.

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

Jared C Malke, Julie M Simon, Christine B. Peterson, 2021, Science.

Pilot study of intratumoral (IT) cryoablation (cryo) in combination with systemic checkpoint blockade in patients with metastatic melanoma (MM)

J. Wargo, P. Sharma, R. Amaria, 2015, Journal of Immunotherapy for Cancer.

Abstract 2838: The gut microbiome (GM) and immunotherapy response are influenced by host lifestyle factors

J. McQuade, B. Helmink, J. Wargo, 2019, Tumor Biology.

Changes in outcomes and factors associated with survival in melanoma patients with brain metastases

Betty Y. S. Kim, S. McGovern, J. Huse, 2022, Neuro-oncology.

Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma.

N. Ajami, J. McQuade, C. Daniel, 2023, JAMA dermatology.